=============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES ACT OF 1934
HEMAGEN DIAGNOSTICS, INC.
--------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 04-2869857
-------------------------- --------------------------------------
(State of Incorporation) (I.R.S. Employer Identification No.)
34-40 Bear Hill Road
Waltham, Massachusetts 02154
(617) 890-3766
(Address and telephone number of principal executive offices)
Securities to be registered pursuant to Section 12(b) of the Act: NONE
Title of each class to Name of each exchange on which
be so registered each class is to be registered
- - ---------------------- ------------------------------
NONE NONE
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock Purchase Warrants
------------------------------
(Title of Class)
Please Address All Correspondence To:
Paul D. Broude, Esquire
O'Connor, Broude & Aronson
950 Winter Street, Suite 2300
Waltham, Massachusetts 02154
(617) 890-6600
=============================================================================
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant's Securities to be Registered:
A description of the securities to be registered containing the
information required by Item 202 of Regulation S-K is contained in the
Company's June 17, 1996 filing of a Form SB-2 Registration Statement under
the Securities Act of 1933, as amended (the "Registration Statement") and
declared effective on July 9, 1996. The Registration Statement is
incorporated herein by reference.
Item 2. Exhibits.
The following documents have been filed with the Securities and
Exchange Commission (the "Commission") under the Securities Act of 1933 or
the Exchange Act of 1934. The documents are incorporated by reference in
this Registration.
1. Form of Warrant Agreement between the Registrant and
Continental Stock Transfer & Trust Company filed as Exhibit 4 to the
Registrant's SB-2 Registration Statement.
2. The Registrant's Form SB-2 Registration Statement dated
June 17, 1996 and declared effective on July 9, 1996.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the Registrant has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereto duly
authorized.
HEMAGEN DIAGNOSTICS, INC.
By: /s/ Carl Franzblau
---------------------------------------
Carl Franzblau, Chief Executive Officer
Date: July 11, 1996
